No Evidence of SARS-CoV-2 Transfusion Transmission or Viral Infectivity About 20-25% of individuals infected with SARS-CoV-2 develop severe symptoms, but many infected individuals are asymptomatic and may donate blood… October 21, 2020
Meta-Analysis Examines Leukapheresis in Patients with Acute Myeloid Leukemia and Hyperleukocytosis Hyperleukocytosis (a white blood cell count greater than 100 X 109/L) is a medical emergency with a mortality rate up… October 14, 2020
Serosurveillance of SARS-CoV-2 from Blood Donations across the U.S. The RESPONSE (REDS-IV-P Epidemiology, Surveillance and Preparedness of the Novel SARS-CoV-2 Epidemic) Study aims to screen blood donations and monitor… October 7, 2020
COVID-19 Pandemic Impacts Blood Donation Trends In order to assess the effect of the COVID-19 pandemic on blood donations, researchers at OneBlood in Florida reviewed 264,593… October 7, 2020
COVID-19 Convalescent Plasma Provides More than Neutralizing Antibodies With few drugs to combat SARS-CoV-2 infections and the approval from the U.S. FDA for Emergency Use Authorization of COVID-19… September 30, 2020
Less than 2% of U.S. Blood Donations Positive for SARS-CoV-2 Antibodies In order to gain a better understanding of SARS-CoV-2 seroprevalence, the American Red Cross tested all blood donations from June… September 22, 2020
Minimal Concerns for HIV in the US Blood Supply after FDA Revised Guidance In 2015, the U.S. FDA revised guidance for blood donor deferral of men who have sex with men (MSM) from… September 15, 2020
NIH Urges Randomized Controlled Trials for COVID-19 Convalescent Plasma On September 1, 2020, shortly after the U.S. Food and Drug’s Emergency Use Authorization (EUA) for the use of COVID-19… September 9, 2020
High-throughput Blood Antigen Array Genotyping for Blood Donors Alloimmunization to red blood cell (RBC), human leukocyte (HLA), and human platelet (HPA) antigens can lead to hemolytic transfusion reactions… September 1, 2020
FDA Issues Emergency Use Authorization for COVID-19 Convalescent Plasma To increase access to COVID-19 convalescent plasma (CCP) use, President Trump, in conjunction with the U.S. FDA, announced Emergency Use… August 25, 2020
